10000m drilling campaign has commenced more than 4 weeks ago, for multiple commodity metals. Assay results are a few weeks away I guess. This stock looks like a very exciting bet too me due to its super low MC, giving it a very exciting risk/reward profile.
Add on top of it is the announcement today of a new play in Canada for REE-Niobium project with 2 diamond drill holes of crazy interception thickness (~500m thickness) with some sections of up to 1.77% TREO. Interception thickness is amazing. They will need to drill closer to the core of the deposit to hit higher grade. Fingers crossed.
If current drilling hits interception of high grade nickel and/or REE or Cobalt or gold, this stock has a huge potential to make everyone rich, very rich indeed because of its current super low MC.
Here is an aspiring story of a nickel stock.
- Forums
- ASX - By Stock
- MTM
- Ann: Advanced Carbonatite REE Project Acquired
Ann: Advanced Carbonatite REE Project Acquired, page-80
-
- There are more pages in this discussion • 351 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MTM (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.8¢ |
Change
0.001(2.70%) |
Mkt cap ! $10.68M |
Open | High | Low | Value | Volume |
4.0¢ | 4.0¢ | 3.8¢ | $12.82K | 330.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 122257 | 3.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 122257 | 0.037 |
2 | 65020 | 0.036 |
2 | 430000 | 0.035 |
6 | 334647 | 0.034 |
4 | 292961 | 0.033 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 100000 | 1 |
0.041 | 168721 | 2 |
0.042 | 350000 | 2 |
0.043 | 24186 | 1 |
0.044 | 100000 | 1 |
Last trade - 15.55pm 12/07/2024 (20 minute delay) ? |
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
MTM (ASX) Chart |